Erratum: A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer (Annals of Oncology (2005) vol. 16 (1639-1645)

H. Oettle, D. Richards, R. K. Ramanathan, J. L. van Laethem, M. Peeters, M. Fuchs, A. Zimmermann, W. John, D. Von Hoff, M. Arning, H. L. Kindler, Jen Shi Chen, Yee Chao

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Erratum: A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer (Annals of Oncology (2005) vol. 16 (1639-1645)'. Together they form a unique fingerprint.